Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

Autor: Hodan, Rachel, Rodgers-Fouche, Linda, Chittenden, Anu, Dominguez-Valentin, Mev, Ferriss, James, Gima, Lauren, Hamnvik, Ole-Petter R., Idos, Gregory E., Kline, Kevin, Koeller, Diane R., Long, Jessica M., McKenna, Danielle, Muller, Charles, Thoman, Maxton, Wintner, Anton, Bedrick, Bronwyn S.
Předmět:
Zdroj: Familial Cancer; Oct2023, Vol. 22 Issue 4, p437-448, 12p
Abstrakt: Transgender and gender diverse (TGD) populations with hereditary cancer syndromes face unique obstacles to identifying and obtaining appropriate cancer surveillance and risk-reducing procedures. There is a lack of care provider knowledge about TGD health management. Lynch syndrome (LS) is one of the most common hereditary cancer syndromes, affecting an estimated 1 in 279 individuals. There are no clinical guidelines specific for TGD individuals with LS, highlighting a need to improve the quality of care for this population. There is an urgent need for cancer surveillance recommendations for TGD patients. This commentary provides recommendations for cancer surveillance, risk-reducing strategies, and genetic counseling considerations for TGD patients with LS. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index